Evaluation of Anthranilamide Derivatives on Learning and Memory Processes in Naïve Rats: In Silico Predictions and In Vivo Behavioral Profiling
Open Access
Abstract
Background: Anthranilamides have attracted increasing attention due to their antispasmodic and anti-inflammatory effects. The present study aimed to comparatively evaluate the effects of three previously synthesized anthranilamides, namely 2-chloro-N-(2-(phenethylcarbamoyl)phenyl)benzamide (1), 2-amino-N-(3-chlorophenethyl)benzamide (2), and 2-(2-chloro-2-phenylacetamido)-N-(3,4-dimethoxyphenethyl)benzamide (3), on cognitive functions in rats and to find if those molecules could act as potential active substances for the treatment of diseases of cognitive dysfunctions. Preclinical evidence and in silico calculations suggest that these compounds may affect the acetylcholinesterase activity, which could indirectly enhance cognitive performance. Methods: Two-way active avoidance test, activity cage test, and two passive avoidance tests—step-through and step-down test—were performed. Naïve male Wistar rats were divided into 4 groups (8 rats in each group): the control group treated with DMSO and the experimental groups with the tested compounds, orally at a dose of 5 mg/kg. Results: The synthesized compounds did not impair the locomotor activity of the tested rats, with no apparent signs of motor suppression during the activity cage test. In the active avoidance test, compound (3) impaired both learning and the long-term memory test, compound (2) increased the number of conditioned stimuli responses on the 12th day as a sign of improved long-term memory, while compound (1) did not affect performance in this test. In the step-down test for passive avoidance learning it was established that compound (2) has a positive impact on the process of learning, whereas compound (1) improves learning, short-term memory, and long-term memory. Conclusions: Our results demonstrate that anthranilamide derivatives do not produce a pronounced depressant or stimulant effect on the central nervous system. Compounds (1) and (2) showed cognitive-enhancing properties, with effects varying depending on the behavioral paradigm applied. These findings highlight the potential of specific anthranilamide derivatives as modulators of learning and memory processes.Keywords
Funding Information
- National Fund for Scientific Research in Bulgaria (KP-06-H73/11)
- Medical University of Plovdiv (NO-26/2025)
This publication has 71 references indexed in Scilit:
- In silico, synthesis and anticancer evaluation of benzamide tryptamine derivatives as novel eEF2K inhibitorsBioorganic & Medicinal Chemistry Letters, 2022
- Anthranilamides with quinoline and β-carboline scaffolds: design, synthesis, and biological activityMolecular Diversity, 2022
- Medicinal chemistry of anthranilic acid derivatives: A mini reviewDrug Development Research, 2021
- A reappraisal of acute doses of benzodiazepines as a model of anterograde amnesiaHuman Psychopharmacology: Clinical and Experimental, 2020
- 1,4-Dihydroquinazolin-3(2H)-yl benzamide derivatives as anti-inflammatory and analgesic agents with an improved gastric profile: Design, synthesis, COX-1/2 inhibitory activity and molecular docking studyBioorganic Chemistry, 2019
- β-amyloid Peptides and Amyloid Plaques in Alzheimer's DiseaseNeurotherapeutics, 2015
- Microwave assisted synthesis and docking study of N-(2-oxo-2-(4-oxo-2-substituted thiazolidin-3ylamino)ethyl)benzamide derivatives as anticonvulsant agentsBioorganic & Medicinal Chemistry Letters, 2014
- Effects of Methyl and Isopropyl N‐methylanthranilates from Choisya ternata Kunth (Rutaceae) on Experimental Anxiety and Depression in MicePhytotherapy Research, 2012
- Learning and memory impairments in a congenic C57BL/6 strain of mice that lacks the M2 muscarinic acetylcholine receptor subtypeBehavioural Brain Research, 2008
- The role of acetylcholine in learning and memoryCurrent Opinion in Neurobiology, 2006